A high-density genome-wide association screen of sporadic als in US veterans

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Kwee, Lydia Coulter ^a,b   Liu, Yutao ^a,b   Haynes, Carol ^b   Gibson, Jason R ^a,b   Stone, Annjanette ^c   Schichman, Steven A ^c,d   Kamel, Freya ^e   Nelson, Lorene M ^f   Topol, Barbara ^f   van Den Eeden, Stephen K ^g   Tanner, Caroline M ^h   Cudkowicz, Merit E ⁱ   Grasso, Daniela L ⁱ   Lawson, Robert ⁱ   Muralidhar, Sumitra ^j   Oddone, Eugene Z ^a,b   Schmidt, Silke ^a,b   Hauser, Michael A ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h PARKINSON S INSTITUTE   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j DEPARTMENT OF VETERANS AFFAIRS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CACNA2D3 GENE; CASE CONTROL STUDY; CAUCASIAN; CCDC93 GENE; CDH8 GENE; CONTROLLED STUDY; CTSC GENE; DPP6 GENE; ELF3 GENE; EN1 GENE; FEMALE; GCNT4 GENE; GENE; GENE LOCATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENOTYPE; HEREDITY; HUMAN; INCIDENCE; INSIG2 GENE; ITPR2 GENE; KIFAP3 GENE; LOC100506746 GENE; LOC285419 GENE; LOC647946 GENE; MACROD2 GENE; MAJOR CLINICAL STUDY; MALE; NUFIP1 GENE; NUFIPI GENE; OUTCOME ASSESSMENT; PARK2 GENE; PATHOGENESIS; PCSK2 GENE; PHENOTYPE; RGS6 GENE; SETBP1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; UNC13A GENE; UNC13C GENE; UNITED STATES; VETERAN; ZNF704 GENE; ZNRF3 GENE; AGED; FOLLOW UP; GENETICS; HUMAN GENOME; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

DIPEPTIDYL PEPTIDASE; DPP6 PROTEIN, HUMAN; NERVE PROTEIN; POTASSIUM CHANNEL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; UNITED STATES; VETERANS;

EID: 84859015231     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032768     Document Type: Article

References (50)

1. Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, et al. (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81: 385-390.
2. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, et al. (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82: 623-627.
3. Simpson CL, Lemmens R, Miskiewicz K, Broom WJ, Hansen VK, et al. (2009) Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet 18: 472-481.
4. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, et al. (2007) Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357: 775-788.
5. van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, et al. (2007) ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 6: 869-877.
6. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, et al. (2008) A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17: 768-774.
7. van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, et al. (2008) Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 40: 29-31.
8. Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, et al. (2009) Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 106: 9004-9009.
9. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, et al. (2009) Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41: 1083-1087.
10. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, et al. (2010) Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9: 978-985.
11. Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, et al. (2010) Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 9: 986-994.
12. Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O, (2009) Screening for replication of genome-wide SNP associations in sporadic ALS. Eur J Hum Genet 17: 213-218.
13. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, et al. (2007) Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 6: 322-328.
14. Chio A, Schymick JC, Restagno G, Scholz SW, Lombardo F, et al. (2009) A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 18: 1524-1532.
15. Van Es MA, Van Vught PW, Veldink JH, Andersen PM, Birve A, et al. (2009) Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10: 441-447.
16. Fernandez-Santiago R, Sharma M, Berg D, Illig T, Anneser J, et al. (2011) No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort. Neurobiol Aging 32: 551 e551-554.
17. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, et al. (2011) A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 72: 257-268.
18. Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 72: 245-256.
19. Wang H, O'Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, et al. (2011) Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol 68: 207-213.
20. Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, et al. (2009) Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol 65: 378-385.
21. Schmidt S, Kwee LC, Allen KD, Oddone EZ, (2010) Association of ALS with head injury, cigarette smoking and APOE genotypes. J Neurol Sci 291: 22-29.
22. Chen H, Richard M, Sandler DP, Umbach DM, Kamel F, (2007) Head injury and amyotrophic lateral sclerosis. Am J Epidemiol 166: 810-816.
23. Binazzi A, Belli S, Uccelli R, Desiato MT, Talamanca IF, et al. (2009) An exploratory case-control study on spinal and bulbar forms of amyotrophic lateral sclerosis in the province of Rome. Amyotroph Lateral Scler 10: 361-369.
24. Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, et al. (2010) Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol 171: 1126-1133.
25. Campbell AM, Williams ER, Barltrop D, (1970) Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry 33: 877-885.
26. Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, et al. (2005) Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis 2: 195-201.
27. Gresham LS, Molgaard CA, Golbeck AL, Smith R, (1986) Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study. Neuroepidemiology 5: 29-38.
28. Bonvicini F, Marcello N, Mandrioli J, Pietrini V, Vinceti M, (2010) Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study. Ann Ist Super Sanita 46: 284-287.
29. Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, et al. (2009) Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler 10: 302-309.
30. Mattsson P, Lonnstedt I, Nygren I, Askmark H, (2010) Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry.
31. Beghi E, Logroscino G, Chio A, Hardiman O, Millul A, et al. (2010) Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler 11: 289-292.
32. Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, et al. (2008) Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology 31: 28-32.
33. Haley RW, (2003) Excess incidence of ALS in young Gulf War veterans. Neurology 61: 750-756.
34. Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, et al. (2003) Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 61: 742-749.
35. Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, et al. (2005) Prospective study of military service and mortality from ALS. Neurology 64: 32-37.
36. Allen KD, Kasarskis EJ, Bedlack RS, Rozear MP, Morgenlander JC, et al. (2008) The National Registry of Veterans with amyotrophic lateral sclerosis. Neuroepidemiology 30: 180-190.
37. Brooks BR, Miller RG, Swash M, Munsat TL, (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293-299.
38. Brooks BR, (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124 (Suppl): 96-107.
39. Schmidt S, Allen KD, Loiacono VT, Norman B, Stanwyck CL, et al. (2008) Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology 30: 191-204.
40. Consortium WTCC, (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
41. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al. (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9: 356-369.
42. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
43. Mata IF, Lockhart PJ, Farrer MJ, (2004) Parkin genetics: one model for Parkinson's disease. Hum Mol Genet 13 Spec No 1: R127-133.
44. Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, et al. (2011) Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82: 638-642.
45. Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, et al. (2010) A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler 11: 542-548.
46. Zheng X, Ren W, Zhang S, Liu J, Li S, et al. (2011) Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Mol Biol Rep.
47. Leak TS, Keene KL, Langefeld CD, Gallagher CJ, Mychaleckyj JC, et al. (2007) Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population. Mol Genet Metab 92: 145-150.
48. Yoshida H, Ohagi S, Sanke T, Furuta H, Furuta M, et al. (1995) Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes 44: 389-393.
49. Traynor BJ, Nalls M, Lai SL, Gibbs RJ, Schymick JC, et al. (2010) Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc Natl Acad Sci U S A 107: 12335-12338.
50. Dion PA, Daoud H, Rouleau GA, (2009) Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 10: 769-782.